It has been demonstrated that several gene alterations are related to a poorer prognosis in PCNSL patients, including deletions or somatic mutations of HLA genes, mutations of CD79B and GNA13, high phosphorylated STAT6 expression, and a high level of CNVs [72,92]. This evidence concerns the gene CD79B and primary central nervous system lymphoma.